LPL Financial
MIRA icon

LPL Financial’s MIRA Pharmaceuticals MIRA Stock Holding History

LPL Financial’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,000
Closed -$65K – 5389
2024
Q3 		$65K Buy
+50,000
New +$79.7K ﹤0.01% 4961

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

LPL Financial's MIRA Position: Q4 2024 in Review

LPL Financial sold out of MIRA Pharmaceuticals (MIRA) in Q4 2024, closing a stake of 50,000 shares — an estimated $65K sold.

LPL Financial first reported a position in MIRA in Q3 2024 and held it in 1 quarter. The position peaked at $65K in Q3 2024. 24 funds tracked by Wall St. Rank hold MIRA as of Q4 2024.

  • LPL Financial reported no remaining MIRA Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • LPL Financial sold 50,000 MIRA Pharmaceuticals shares in Q4 2024, an estimated $65K.
  • LPL Financial first reported a position in MIRA Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • LPL Financial's MIRA Pharmaceuticals position peaked at $65K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.